These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29982822)

  • 21. Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-analysis.
    Shah A; Pakeerathan V; Jones MP; Kashyap PC; Virgo K; Fairlie T; Morrison M; Ghoshal UC; Holtmann GJ
    J Neurogastroenterol Motil; 2023 Apr; 29(2):132-144. PubMed ID: 37019859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
    Weinstock LB; Geng B; Brandes SB
    Can J Urol; 2011 Aug; 18(4):5826-30. PubMed ID: 21854715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chinese herbal medicine for the treatment of small intestinal bacterial overgrowth (SIBO): A protocol for systematic review and meta-analysis.
    Ren X; Di Z; Zhang Z; Fu B; Wang Y; Huang C; Du Y
    Medicine (Baltimore); 2020 Dec; 99(51):e23737. PubMed ID: 33371127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis.
    Rao SSC; Rehman A; Yu S; Andino NM
    Clin Transl Gastroenterol; 2018 Jun; 9(6):162. PubMed ID: 29915215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics].
    Lykova EA; Bondarenko VM; Parfenov AI; Matsulevich TV
    Eksp Klin Gastroenterol; 2005; (6):51-7, 113. PubMed ID: 17378388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis.
    Wang J; Zhang L; Hou X
    Expert Rev Gastroenterol Hepatol; 2021 Dec; 15(12):1385-1399. PubMed ID: 34767484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
    Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
    Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
    Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
    J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal calprotectin in systemic sclerosis and review of the literature.
    Marie I; Leroi AM; Menard JF; Levesque H; Quillard M; Ducrotte P
    Autoimmun Rev; 2015 Jun; 14(6):547-54. PubMed ID: 25661980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.
    Furnari M; Parodi A; Gemignani L; Giannini EG; Marenco S; Savarino E; Assandri L; Fazio V; Bonfanti D; Inferrera S; Savarino V
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1000-6. PubMed ID: 20937045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small intestinal bacterial overgrowth.
    Rana SV; Bhardwaj SB
    Scand J Gastroenterol; 2008; 43(9):1030-7. PubMed ID: 18609165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Ursodeoxycholic Acid on Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia: A Pilot Randomized Controlled Trial.
    Kim BT; Kim KM; Kim KN
    Nutrients; 2020 May; 12(5):. PubMed ID: 32422942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
    Lauritano EC; Gabrielli M; Scarpellini E; Lupascu A; Novi M; Sottili S; Vitale G; Cesario V; Serricchio M; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2008 Aug; 103(8):2031-5. PubMed ID: 18802998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiome in systemic sclerosis: a potential therapeutic target.
    Polkowska-Pruszyńska B; Gerkowicz A; Rawicz-Pruszyński K; Krasowska D
    Postepy Dermatol Alergol; 2022 Feb; 39(1):101-109. PubMed ID: 35369617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence.
    Zhong C; Qu C; Wang B; Liang S; Zeng B
    J Clin Gastroenterol; 2017 Apr; 51(4):300-311. PubMed ID: 28267052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
    Moraru IG; Portincasa P; Moraru AG; Diculescu M; Dumitraşcu DL
    Rom J Intern Med; 2013; 51(3-4):143-7. PubMed ID: 24620626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.
    Cuoco L; Salvagnini M
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):89-95. PubMed ID: 16554709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response.
    Greco A; Caviglia GP; Brignolo P; Ribaldone DG; Reggiani S; Sguazzini C; Smedile A; Pellicano R; Resegotti A; Astegiano M; Bresso F
    Scand J Gastroenterol; 2015; 50(11):1376-81. PubMed ID: 25990116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study].
    Soifer LO; Peralta D; Dima G; Besasso H
    Acta Gastroenterol Latinoam; 2010 Dec; 40(4):323-7. PubMed ID: 21381407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.